Discover 749 paid clinical trials in Sacramento, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 749
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: St. Helena CA, Fremont CA, San Francisco CA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 0+
Code: NCT04242095
Recruiting
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
for
Cigarette Smoking-Related Carcinoma
Location: St. Helena CA, Carson City NV, Reno NV, Kingman AZ,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT05008848
Phase3, Recruiting
Tracking Results of Ablations to Combat AF Registry Generation 2
for
Atrial Fibrillation
Location: St. Helena CA, Loma Linda CA, Glenwood Springs CO,
Sponsor: AtriCure, Inc.
Sex: All
Age: 18+
Code: NCT05111015
Recruiting
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
for
Atrial Fibrillation, Maze Procedure, AF, Ablation
Location: St. Helena CA, Ann Arbor MI, Orlando FL
Sponsor: Pulse Biosciences, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06959121
Recruiting
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
for
Clonal Mast Cell Disease, KIT D816V Mutation,
Location: Walnut Creek CA, San Diego CA, Lincoln NE,
Sponsor: Blueprint Medicines Corporation
Sex: All
Age: 18+
Code: NCT07143669
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
for
Glaucoma
Location: Walnut Creek CA, San Francisco CA, Toronto, Buffalo NY,
Sponsor: University of Pennsylvania
Sex: All
Age: 18+
Code: NCT05924477
Recruiting
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
for
DLBCL, Diffuse Large B-Cell Lymphoma
Location: Walnut Creek CA, Las Vegas NV, Glendale AZ, Billings MT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05139017
Phase2, Phase3, Recruiting
Urine Metabolites in the Diagnosis of Disease
for
Colorectal Cancer,
Location: Walnut Creek CA, Santa Monica CA, Encinitas CA
Sponsor: Luventix, Inc.
Sex: All
Age: 18+
Code: NCT06710067
Recruiting
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
for
Lymphoma, Large B-Cell, Diffuse
Location: Walnut Creek CA, Burbank CA, Duarte CA, St. George UT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06890884
Phase2, Recruiting
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
for
Chronic Pain
Location: Walnut Creek CA
Sponsor: CereVu Medical, Inc.
Sex: All
Age: 18+
Code: NCT06559735
Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
for
Nausea, Vomiting,
Location: Walnut Creek CA, Greenbrae CA, Medford OR,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07169851
Phase2, Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
for
Non-Small Cell Lung Cancer (NSCLC)
Location: Walnut Creek CA, Monterey CA, Beverly Hills CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361510
Phase3, Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Walnut Creek CA, Palo Alto CA, Los Angeles CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase3, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Location: Walnut Creek CA, Medford OR, Los Angeles CA, Eugene OR,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06119581
Phase3, Recruiting
Dementia and Diabetes Prevention Program
for
Diabetes, Dementia
Location: Walnut Creek CA
Sponsor: University of California, Davis
Sex: All
Age: 60+
Code: NCT04141878
Recruiting
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
for
Geographic Atrophy of the Macula
Location: Walnut Creek CA, Beverly Hills CA
Sponsor: Galimedix Therapeutics Inc
Sex: All
Age: 55+
Code: NCT06659549
Phase2, Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
for
Geographic Atrophy, Macular Degeneration
Location: Walnut Creek CA, Reno NV, Oxnard CA, Pasadena CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 60+
Code: NCT06635148
Phase2, Phase3, Recruiting
Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants
for
Macular Telangiectasia Type 2 (MacTel)
Location: Walnut Creek CA, Palo Alto CA, Portland OR,
Sponsor: Neurotech Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06971939
Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Walnut Creek CA, Campbell CA, Bakersfield CA, Oxnard CA,
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT07215390
Phase2, Recruiting
Fructose Intestinal Gluconeogenesis
for
Healthy Participants, Obese But Otherwise Healthy Participants